Cargando…
Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival
BACKGROUND: Evidences about survival of the patients with head and neck squamous cell carsinoma (HNSCC) have been scant in our region. OBJECTIVES: The aim of current study was to determine clinico-pathological and treatment-related factors, influencing outcome of these patients. PATIENTS AND METHODS...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667237/ https://www.ncbi.nlm.nih.gov/pubmed/26634109 http://dx.doi.org/10.17795/ijcp-3842 |
_version_ | 1782403807453380608 |
---|---|
author | Novin, Kambiz Ameri, Ahmad Faraji, Saba Torbati, Peyman Mortazavi, Nafiseh |
author_facet | Novin, Kambiz Ameri, Ahmad Faraji, Saba Torbati, Peyman Mortazavi, Nafiseh |
author_sort | Novin, Kambiz |
collection | PubMed |
description | BACKGROUND: Evidences about survival of the patients with head and neck squamous cell carsinoma (HNSCC) have been scant in our region. OBJECTIVES: The aim of current study was to determine clinico-pathological and treatment-related factors, influencing outcome of these patients. PATIENTS AND METHODS: We have reviewed all patients with a new diagnosis of HNSCC admitted between 2008 and 2014 in “Jorjani Cancer Center”, Tehran, Iran. Overall survival (OS) and event free survival (EFS) of the patients, and their relation with demographic and clinico-pathological factors have been analyzed. RESULTS: Among 119 included patients, 90 were male and 29 were female with mean age of 58 years. Larynx was the most common primary tumor site (55% of all patients). With a median follow-up period of 28 months, OS and EFS of the study patients was 61.2% and 52.4%, respectively. Tumor stage was the only parameter has significantly influenced the patients’ OS. Patients with normal BMIs had significantly higher mean EFS compared with patients with bellow or above normal BMIs. Surgical treatment modalities have resulted in the same prognosis as non-surgical approaches. CONCLUSIONS: Our study seems to be the first that investigated outcome of Iranian patients with head and neck cancer and its influencing factors. |
format | Online Article Text |
id | pubmed-4667237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Shahid Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-46672372015-12-02 Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival Novin, Kambiz Ameri, Ahmad Faraji, Saba Torbati, Peyman Mortazavi, Nafiseh Iran J Cancer Prev Research Article BACKGROUND: Evidences about survival of the patients with head and neck squamous cell carsinoma (HNSCC) have been scant in our region. OBJECTIVES: The aim of current study was to determine clinico-pathological and treatment-related factors, influencing outcome of these patients. PATIENTS AND METHODS: We have reviewed all patients with a new diagnosis of HNSCC admitted between 2008 and 2014 in “Jorjani Cancer Center”, Tehran, Iran. Overall survival (OS) and event free survival (EFS) of the patients, and their relation with demographic and clinico-pathological factors have been analyzed. RESULTS: Among 119 included patients, 90 were male and 29 were female with mean age of 58 years. Larynx was the most common primary tumor site (55% of all patients). With a median follow-up period of 28 months, OS and EFS of the study patients was 61.2% and 52.4%, respectively. Tumor stage was the only parameter has significantly influenced the patients’ OS. Patients with normal BMIs had significantly higher mean EFS compared with patients with bellow or above normal BMIs. Surgical treatment modalities have resulted in the same prognosis as non-surgical approaches. CONCLUSIONS: Our study seems to be the first that investigated outcome of Iranian patients with head and neck cancer and its influencing factors. Shahid Beheshti University of Medical Sciences 2015-10-27 2015-10 /pmc/articles/PMC4667237/ /pubmed/26634109 http://dx.doi.org/10.17795/ijcp-3842 Text en Copyright © 2015, Iranian Journal of Cancer Prevention. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Research Article Novin, Kambiz Ameri, Ahmad Faraji, Saba Torbati, Peyman Mortazavi, Nafiseh Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival |
title | Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival |
title_full | Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival |
title_fullStr | Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival |
title_full_unstemmed | Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival |
title_short | Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival |
title_sort | head and neck squamous cell carcinoma in iran: clinico-pathological and treatment-related factors influencing survival |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667237/ https://www.ncbi.nlm.nih.gov/pubmed/26634109 http://dx.doi.org/10.17795/ijcp-3842 |
work_keys_str_mv | AT novinkambiz headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival AT ameriahmad headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival AT farajisaba headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival AT torbatipeyman headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival AT mortazavinafiseh headandnecksquamouscellcarcinomainiranclinicopathologicalandtreatmentrelatedfactorsinfluencingsurvival |